KFSC
BIO icon

Keystone Financial Services (Colorado)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Keystone Financial Services (Colorado)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-719
Closed -$236K – 102
2024
Q4 		$236K Buy
+719
New +$244K 0.09% 89

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Veritas Asset Management
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Keystone Financial Services (Colorado)'s BIO Position: Q1 2025 in Review

Keystone Financial Services (Colorado) sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 719 shares — an estimated $236K sold.

Keystone Financial Services (Colorado) first reported a position in BIO in Q4 2024 and held it in 1 quarter. The position peaked at $236K in Q4 2024. 437 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Keystone Financial Services (Colorado) reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Keystone Financial Services (Colorado) sold 719 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $236K.
  • Keystone Financial Services (Colorado) first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 1 quarter.
  • Keystone Financial Services (Colorado)'s Bio-Rad Laboratories Class A position peaked at $236K in Q4 2024.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Keystone Financial Services (Colorado)'s 13F filing for Q1 2025, filed 23 Apr 2025.